
|Articles|July 27, 2022
Medidata Supports White House Cancer Moonshot Effort
Advertisement
Medidata is supporting the White House Cancer Moonshot initiative by working with the National Cancer Institute (NCI) to enroll patients in the Cancer Moonshot Biobank.
The Cancer Moonshot Biobank relies on Medidata’s Patient Cloud and Rave solutions, including eConsent and Rave EDC (electronic data capture).
Read more about Medidata's involvement
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5




